Q2 FY2026 · ended Jun 30, 2026 · Revenue $26.65M, +7.0% YoY · Filed Aug 12, 2026
Mannatech Inc (MTEX) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $26.6 million and net income of $1.0 million. Free cash flow was -$802,000. As of Jun 30, 2026 it held $6.0 million in cash and investments and $6.3 million in total debt.
Revenue
$26.65M
+7.0% vs prior quarter
Net income
$1.01M
+6.8% vs prior quarter
Operating cash flow
$-792,000
-170.3% vs prior quarter
Free cash flow
$-802,000
-180.4% vs prior quarter
EPS
$0.53
+8.2% vs prior quarter
Dividend per share
$0.00
Shares outstanding
1.93M
+0.0% vs prior quarter
Net cash
$-311,000
Q2 FY2026
Operating margin
3.7%
Q2 FY2026
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- MTEX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Flower Mound, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1056358
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q1 FY2025 Mar 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $26.6M | $24.9M | $26.6M | $29.2M | $26.6M |
| Operating income | $998,000 | -$180,000 | -$157,000 | $2.0M | -$833,000 |
| Net income | $1.0M | $950,000 | -$11.3M | $1.9M | -$1.5M |
| Diluted EPS | $0.53 | $0.49 | -$5.94 | $1.01 | -$0.80 |
| Operating cash flow | -$792,000 | $1.1M | -$289,000 | -$2.7M | -$1.4M |
| Free cash flow | -$802,000 | $997,000 | -$463,000 | -$3.9M | -$1.9M |
| Total assets | $27.5M | $29.9M | $30.0M | $33.9M | $36.7M |
| Total liabilities | $32.4M | $35.4M | $35.2M | $27.0M | $29.1M |
| Stockholders' equity | -$5.0M | -$5.6M | -$5.2M | $7.0M | $7.6M |
| Cash and investments | $6.0M | $7.0M | $6.2M | $7.1M | $9.3M |
| Total debt | $6.3M | $6.8M | $7.4M | $8.1M | $6.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K/A |
Amended current report
Auditor change
|
Oct 23, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 21, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
All 1000 Mannatech Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.